-
15261-10A retinoic acid receptor agonist that is selective for RAR&alpha (Kd = 8 nM AC50 = 0.36 nM) compared to RAR&beta (Kd = 131 nM AC50 = 24.
-
15261-25A retinoic acid receptor agonist that is selective for RAR&alpha (Kd = 8 nM AC50 = 0.36 nM) compared to RAR&beta (Kd = 131 nM AC50 = 24.
-
15261-5A retinoic acid receptor agonist that is selective for RAR&alpha (Kd = 8 nM AC50 = 0.36 nM) compared to RAR&beta (Kd = 131 nM AC50 = 24.
-
16316-1A novel CB1 selective neutral antagonist with low CNS penetration (Ki = 1.7 and 523 nM for CB1 and CB2, respectively) reduces food intake, food-reinforced behavior and weight gain improves metabolic profiles of mice with diet-induced obesity.
-
16316-10A novel CB1 selective neutral antagonist with low CNS penetration (Ki = 1.7 and 523 nM for CB1 and CB2, respectively) reduces food intake, food-reinforced behavior and weight gain improves metabolic profiles of mice with diet-induced obesity.
-
16316-25A novel CB1 selective neutral antagonist with low CNS penetration (Ki = 1.7 and 523 nM for CB1 and CB2, respectively) reduces food intake, food-reinforced behavior and weight gain improves metabolic profiles of mice with diet-induced obesity.
-
16316-5A novel CB1 selective neutral antagonist with low CNS penetration (Ki = 1.7 and 523 nM for CB1 and CB2, respectively) reduces food intake, food-reinforced behavior and weight gain improves metabolic profiles of mice with diet-induced obesity.
-
71770-10A retinoic acid receptor agonist that is selective for RAR&alpha (Kd = 62 nM AC50 = 1.46 nM) compared to RAR&beta (Kd = 280 nM AC50 = 6.
-
71770-25A retinoic acid receptor agonist that is selective for RAR&alpha (Kd = 62 nM AC50 = 1.46 nM) compared to RAR&beta (Kd = 280 nM AC50 = 6.
-
71770-5A retinoic acid receptor agonist that is selective for RAR&alpha (Kd = 62 nM AC50 = 1.46 nM) compared to RAR&beta (Kd = 280 nM AC50 = 6.
-
71770-50A retinoic acid receptor agonist that is selective for RAR&alpha (Kd = 62 nM AC50 = 1.46 nM) compared to RAR&beta (Kd = 280 nM AC50 = 6.
-
16719-1A slow, tight binding, competitive aminopeptidase (AP) inhibitor, first described as an inhibitor of AP-A (glutamyl AP IC<sub>50</sub> = 0.54 µg/ml) but not of AP-B (arginine AP) also inhibits AP-N (AP-M, alanyl AP Ki = 20-200 nM),